Market Value791,189,000
Total Holdings40
File Date2019-02-15
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
ICPT / Intercept Pharmaceuticals Inc Put
LRMR / Larimar Therapeutics, Inc.
YMTX / Yumanity Therapeutics Inc
KRYS / Krystal Biotech, Inc.
PTGX / Protagonist Therapeutics, Inc.
IOVA / Iovance Biotherapeutics, Inc.
US00163U1060 / AMAG Pharmaceuticals, Inc.
ARGX / argenx SE - Depositary Receipt (Common Stock)
CTIC / CTI BioPharma Corp
ACER / Acer Therapeutics Inc
ECYT / Endocyte, Inc.
/ Array BioPharma, Inc.
ZYME / Zymeworks Inc.
SRRA / Sierra Oncology Inc
ONCE / Spark Therapeutics, Inc.
STRM / Streamline Health Solutions, Inc.
FOMX / Foamix Pharmaceuticals Ltd.
ZGNX / Zogenix Inc
XLRN / Acceleron Pharma Inc
BOLD / Boundless Bio, Inc.
OSMT / Osmotica Pharmaceuticals Plc
VYGR / Voyager Therapeutics, Inc.
TPST / Tempest Therapeutics, Inc.
ALNY / Alnylam Pharmaceuticals, Inc.
VYNE / VYNE Therapeutics Inc.
UTHR / United Therapeutics Corporation
GBT / Global Blood Therapeutics Inc.
ACAD / ACADIA Pharmaceuticals Inc.
US33830X1046 / Five Prime Therapeutics Inc
KURA / Kura Oncology, Inc.
CBAY / CymaBay Therapeutics, Inc.
PTCT / PTC Therapeutics, Inc.
PBYI / Puma Biotechnology, Inc.
MDGL / Madrigal Pharmaceuticals, Inc.
EXEL / Exelixis, Inc.
VRTX / Vertex Pharmaceuticals Incorporated Put
TGTX / TG Therapeutics, Inc.
SVRA / Savara Inc.
SAGE / Sage Therapeutics, Inc. Put
SAGE / Sage Therapeutics, Inc. Call
ENTA / Enanta Pharmaceuticals, Inc.
ITCI / Intra-Cellular Therapies, Inc. Put
VIRX / Viracta Therapeutics, Inc.
NVAX / Novavax, Inc. Call
CYTK / Cytokinetics, Incorporated
BCRX / BioCryst Pharmaceuticals, Inc.